NYSE:BMY   Bristol-Myers Squibb Company
strength in drug names, $ENDP up 20% after EPS $MNK another one that gap up on EPS. Looking for $BMY to top out at the 63 level a short term 5% move. Hope for the best prepare for the worst.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。